人工臓器バンク市場：製品タイプ、技術、バイオニクス別-2025-2030年の世界予測

人工臓器バンク市場は、2023年に371億米ドルと評価され、2024年には420億4,000万米ドルに達すると予測され、CAGR 13.40％で成長し、2030年には895億3,000万米ドルに達すると予測されています。

人工臓器バンク市場の範囲には、人間の臓器を複製または代替するように設計された人工臓器の開発、保管、流通が含まれます。定義には通常、人体内で特定の生理学的機能を果たすことができる人工の生物学的または機械的構造が含まれます。人工臓器バンクの必要性は、臓器提供の不足が切迫していることに加え、臓器不全に苦しむ人々のために代替臓器を即座に利用できるようにし、待ち時間を短縮して患者の転帰を改善する必要性から生じています。用途は心臓、肝臓、腎臓、肺の代替など広範囲に及び、ヘルスケア分野、移植手術、再生医療に大きな影響を与えています。最終用途は主に、慢性疾患や遺伝性疾患に焦点を当てた病院、診療所、研究機関が中心となっています。市場力学は主に、バイオテクノロジーの進歩、ヘルスケア技術への投資の増加、高齢化、臓器不全の発生率の上昇の影響を受けています。成長要因としては、研究開発活動の活発化、技術統合の強化、ヘルスケア・イノベーションを促進する有利な政府規制などが挙げられます。しかし、開発・製造工程に伴う高コスト、厳しい規制当局の承認、遺伝子組み換えに関する倫理的懸念、人体への組み込みや拒絶反応の問題など、大きな課題も残っています。潜在的なビジネスチャンスは、新興市場における需要の高まりと並んで、バイオプリント技術の拡大と、オーダーメイドの臓器ソリューションを可能にする個別化医療アプローチにあります。非公開会社は、費用対効果の高い生産技術に注力し、官民パートナーシップを促進し、患者の安全性プロファイルを強化することで、市場の限界に対処できると思われます。生体材料、ロボット工学、モニタリングや疾病予測を支援するAIなどの分野では、今後も技術革新が進む可能性があります。市場競争は依然として激しく、その動向は学際的な共同研究や、強固な市場参入戦略を促進するためのM&Aの増加を指し示しています。持続的な成長のためには、品質の向上、応用範囲の拡大、倫理的・法的問題への積極的な対応に重点が置かれます。

市場力学：急速に進化する人工臓器バンク市場の主要市場インサイトを公開

人工臓器バンク市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 老人人口の増加と事故件数の増加
  • 人工臓器移植に対する意識の高まり
  • 臓器提供者の不足
• 市場抑制要因
  • 資本集約的な移植プロセス
  • この分野における専門知識の不足
• 市場機会
  • 研究開発投資の増加
  • 人工インプラントの技術革新とヘルスケア費用の上昇
• 市場の課題
  • 人工臓器に関連するリスクの可能性

ポーターのファイブフォース：人工臓器バンク市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：人工臓器バンク市場における外部からの影響の把握

外部マクロ環境要因は、人工臓器バンク市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析人工臓器バンク市場における競合情勢の把握

人工臓器バンク市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス人工臓器バンク市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、人工臓器バンク市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨人工臓器バンク市場における成功への道筋を描く

人工臓器バンク市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口の増加と事故件数の増加
    • 人工臓器移植への意識の高まり
    • 臓器提供者の不足
  • 抑制要因
    • 資本集約的な移植プロセス
    • 当該分野における専門知識の欠如
  • 機会
    • 研究開発への投資の増加
    • 人工インプラントの技術革新とヘルスケア費の高騰
  • 課題
    • 人工臓器に関連する可能性のあるリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 人工臓器バンク市場生産タイプ別

• 血管
• 耳
• 目
• 心臓
• 腎臓
• 肝臓
• 膵臓

第7章 人工臓器バンク市場：技術別

• 電気
• 機械

第8章 人工臓器バンク市場バイオニクス

• ブレインバイオニック
• カーディアックバイオニック
• イヤーバイオニック
• リムスバイオニック
• ビジョンバイオニック

第9章 南北アメリカの人工臓器バンク市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の人工臓器バンク市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの人工臓器バンク市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abiomed, Inc.
• Berlin Heart GmbH
• Biomet, Inc.
• Boston Scientific Corporation
• Cochlear, Ltd.
• Edwards Lifesciences Corporation
• Ekso Bionics
• HeartWare International, Inc.
• iWALK, Inc.
• Jarvik Heart, Inc.

LIST OF FIGURES

• FIGURE 1. ARTIFICIAL ORGAN BANK MARKET RESEARCH PROCESS
• FIGURE 2. ARTIFICIAL ORGAN BANK MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ARTIFICIAL ORGAN BANK MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ARTIFICIAL ORGAN BANK MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ARTIFICIAL ORGAN BANK MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ARTIFICIAL ORGAN BANK MARKET DYNAMICS
• TABLE 7. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY BLOOD VESSELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY EARS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY EYES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY ELECTRICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY BRAIN BIONIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY CARDIAC BIONIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY EAR BIONIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY LIMBS BIONIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY VISION BIONIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 34. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 51. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 54. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 106. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 118. POLAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 119. POLAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. POLAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 121. QATAR ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 122. QATAR ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. QATAR ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY PRODUCTION TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIONICS, 2018-2030 (USD MILLION)
• TABLE 151. ARTIFICIAL ORGAN BANK MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 152. ARTIFICIAL ORGAN BANK MARKET, FPNV POSITIONING MATRIX, 2023

The Artificial Organ Bank Market was valued at USD 37.10 billion in 2023, expected to reach USD 42.04 billion in 2024, and is projected to grow at a CAGR of 13.40%, to USD 89.53 billion by 2030.

The scope of the artificial organ bank market encompasses the development, storage, and distribution of synthetic organs designed to replicate or replace human organs. Definitions typically include any engineered biological or mechanical structures that can perform specific physiological functions within the human body. The necessity for artificial organ banks stems from pressing shortages in organ donations, alongside the need for immediate availability of replacement organs for those suffering from organ failure, thus reducing waiting times and improving patient outcomes. Applications are widespread, including heart, liver, kidney, and lung replacements, significantly impacting healthcare sectors, transplantation surgeries, and regenerative medicine. End usage primarily centers around hospitals, clinics, and research institutions focusing on chronic ailments and genetic disorders. Market dynamics are chiefly influenced by advances in biotechnology, increasing investment in healthcare technology, an aging population, and rising incidences of organ failures. Growth factors include burgeoning R&D activities, enhancing technologic integration, and favorable government regulations promoting healthcare innovations. However, substantial challenges persist, such as high costs associated with development and manufacturing processes, stringent regulatory approvals, ethical concerns regarding genetic modifications, and issues of integration and rejection by the human body. Potential opportunities lie in expanding bio-printing technologies and personalized medicine approaches that allow for tailored organ solutions, alongside growing demand in emerging markets. Companies could address market limitations by focusing on cost-effective production techniques, fostering public-private partnerships, and enhancing patient safety profiles. Continued innovation may take place within biomaterials, robotics, and AI assisting in monitoring and disease prediction. The market remains highly competitive, with trends pointing towards interdisciplinary collaborations and increased mergers and acquisitions to facilitate robust market entry strategies. For sustained growth, emphasis on quality improvements, expanding application ranges, and proactively addressing ethical and legal issues will be vital.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Organ Bank Market

The Artificial Organ Bank Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing geriatric population and rise in the number of accidents
  • Growing awareness of artificial organ transplant
  • Scarcity of organ donors
• Market Restraints
  • Capital intensive implantation process
  • Lack of expertise in the field
• Market Opportunities
  • Rising investments in research and development
  • Technological innovations in artificial implants and rising expenses of healthcare
• Market Challenges
  • Probable risks pertinent with artificial organs

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Organ Bank Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Organ Bank Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Organ Bank Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Organ Bank Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Organ Bank Market

A detailed market share analysis in the Artificial Organ Bank Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Organ Bank Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Organ Bank Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Organ Bank Market

A strategic analysis of the Artificial Organ Bank Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Organ Bank Market, highlighting leading vendors and their innovative profiles. These include Abiomed, Inc., Berlin Heart GmbH, Biomet, Inc., Boston Scientific Corporation, Cochlear, Ltd., Edwards Lifesciences Corporation, Ekso Bionics, HeartWare International, Inc., iWALK, Inc., and Jarvik Heart, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Organ Bank Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Production Type, market is studied across Blood Vessels, Ears, Eyes, Heart, Kidney, Liver, and Pancreas.
• Based on Technology, market is studied across Electrical and Mechanical.
• Based on Bionics, market is studied across Brain Bionic, Cardiac Bionic, Ear Bionic, Limbs Bionic, and Vision Bionic.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing geriatric population and rise in the number of accidents
    • 5.1.1.2. Growing awareness of artificial organ transplant
    • 5.1.1.3. Scarcity of organ donors
  • 5.1.2. Restraints
    • 5.1.2.1. Capital intensive implantation process
    • 5.1.2.2. Lack of expertise in the field
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising investments in research and development
    • 5.1.3.2. Technological innovations in artificial implants and rising expenses of healthcare
  • 5.1.4. Challenges
    • 5.1.4.1. Probable risks pertinent with artificial organs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Organ Bank Market, by Production Type

• 6.1. Introduction
• 6.2. Blood Vessels
• 6.3. Ears
• 6.4. Eyes
• 6.5. Heart
• 6.6. Kidney
• 6.7. Liver
• 6.8. Pancreas

7. Artificial Organ Bank Market, by Technology

• 7.1. Introduction
• 7.2. Electrical
• 7.3. Mechanical

8. Artificial Organ Bank Market, by Bionics

• 8.1. Introduction
• 8.2. Brain Bionic
• 8.3. Cardiac Bionic
• 8.4. Ear Bionic
• 8.5. Limbs Bionic
• 8.6. Vision Bionic

9. Americas Artificial Organ Bank Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Artificial Organ Bank Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Organ Bank Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abiomed, Inc.
• 2. Berlin Heart GmbH
• 3. Biomet, Inc.
• 4. Boston Scientific Corporation
• 5. Cochlear, Ltd.
• 6. Edwards Lifesciences Corporation
• 7. Ekso Bionics
• 8. HeartWare International, Inc.
• 9. iWALK, Inc.
• 10. Jarvik Heart, Inc.